// App-Quantinova.ai

e12503 : Trastuzumab-related cardiotoxicity in patients with breast cancer with comorbidities of obesity, dyslipidemia, and diabetes.

Researchers

Presenter

  • Olexiy Aseyev

Principal Investigators

  • Christopher Johnson

  • Michele Turek

  • Angeline Law

  • Jeffrey Allen Sulpher

  • Susan Faye Dent

Medical Centers

  • Ottawa Hospital Cancer Center, University of Ottawa, Ottawa, ON, Canada

  • The Ottawa Hospital, Ottawa, ON, Canada

  • The Ottawa Hospital, Ottawa, ON, Canada

  • Ottawa Hospital Cancer Centre, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Congestive heart failure

  • Cardiotoxicity

  • Breast cancer

  • Dyslipidemia

  • Diabetes

  • Obesity

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Trastuzumab

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved